Assays were conducted as described [25]. HL-60 cells were purchased from the American Type Culture Collection and were maintained in 1x RPMI-1640 medium supplemented with 10% [v/v] heat-inactivated fetal bovine serum prior to use. Briefly, 10 μl of bacterial suspension (~700–1000 CFU) was added to 25 μl of antibody in each well for opsonization at 37°C for 15 min in a 5% CO2 incubator, at which point 25 μl of BRC and 4 x 105 HL-60 cells in 40 μl of media were added to each well. The 96 well plate was incubated at 37°C (no CO2) with shaking agitation at 160 rpm for 45 mins. Antibody samples were adjusted prior to addition such that each sample contained an equivalent number of total anti-1925wzzB-COPS IgG EU in the 100 μl assay volume. Negative controls were performed with buffer in place of sera. Viable bacteria were determined after plating on rich media agar.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.